Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Thorough QTc trial of AN 2728 in volunteers.

Trial Profile

Thorough QTc trial of AN 2728 in volunteers.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 13 Nov 2013

At a glance

  • Drugs Crisaborole (Primary)
  • Indications Atopic dermatitis
  • Focus Adverse reactions
  • Most Recent Events

    • 13 Nov 2013 New trial record
    • 12 Nov 2013 The results of this trial are expected before the end of 2013, according to an Anacor Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top